The new research project of Parkinson’s to be conducted by Irish Scientists. This project aims to increase our sense of Parkinson’s disease in order to enhance the treatments.
Currently, more than a million people suffer from Parkinson’s in Europe and this stat is expected to double by 2030. New and enhanced treatments are vital as old drugs are not that effective. Researchers and companies making new drugs need to be educated about how mitochondrial dysfunction is involved in disease evolution.
Parkinson’s is a breakthrough neurological disease, the effects of which encompass tremors, stiffness and sluggish movements. Till date, there is no cure. A million people in Europe are affected, including 12,000 in Ireland.
The Royal College of Surgeons in Ireland (RCSI) will regulate the project – “PD-MitoQUANT.” Their purpose is to enhance our understanding of how brain cells become flawed in people with Parkinson’s.
The project has been supported by the Innovative Medicines Initiative (IMI) with €7 million. IMI is an EU public-private partnership that funds health research. It selected this project as it recognizes the vital need for new and enhanced treatments.
The routine drug used to cure Parkinson’s in Ireland is more than 50 years old, and there is no treatment available that can conclude, slow down or reverse the disease.
14 member from nine countries are involved I this project
“We hope that a systematic understanding of Parkinson’s developed from this project will lead to improved tools for the early stages of drug development. So pharmaceutical companies can develop new treatments in the future,” Dr Connolly said.